Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.2040
+0.0030 (1.49%)
Jul 3, 2026, 5:24 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 175.7 million as of July 2, 2026. Its market cap has decreased by -44.68% in one year.
Market Cap
175.70M
Enterprise Value
187.69M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 175.70M, an increase of 69.46%. That is a compound annual growth rate of 5.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 175.70M | -11.57% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 241.97M |
| Xbrane Biopharma AB | 218.42M |
| Initiator Pharma | 184.82M |
| Elicera Therapeutics AB | 178.19M |
| Diamyd Medical AB | 158.08M |
| Nanologica AB | 157.81M |
| Active Biotech AB | 150.78M |
| Simris Group AB (PUBL) | 132.01M |